Tommy Chung
About Tommy Chung
Tommy Chung is the Associate Director of Financial Analysis for Mergers and Acquisitions at Bristol-Myers Squibb in New York. He has over a decade of experience in financial analysis, economic valuation, and advisory services from previous roles at KPMG, Deloitte, and the American Red Cross.
Current Role at Bristol-Myers Squibb
Tommy Chung is currently serving as the Associate Director of Financial Analysis for Mergers and Acquisitions at Bristol-Myers Squibb. He has been in this position for over a decade, starting his tenure at the company in January 2013. His role involves the financial analysis crucial to mergers and acquisitions, underscoring his expertise in this specialized area of finance.
Previous Experience at KPMG
Prior to his current role, Tommy Chung worked at KPMG from 2011 to 2013 in the Economic Valuation Services division. During his tenure, he honed his skills in economic valuation, a critical component for analyzing the financial implications and sustainability of business operations.
Financial Advisory Services at Deloitte
From 2004 to 2010, Tommy Chung was part of Deloitte's Financial Advisory Services team in New York. In this capacity, he worked extensively on valuation, mergers and acquisitions, and private equity. This six-year period helped build his comprehensive understanding and expertise in multiple facets of financial advisory.
Educational Background
Tommy Chung pursued his higher education at the University of Southern California's Marshall School of Business. He holds a Master's degree, a Master of Arts, a Bachelor's degree, and a Bachelor of Science. This diverse academic background provides a solid foundation for his professional expertise in finance and valuation.
Contribution to American Red Cross
In 2002, Tommy Chung contributed to the American Red Cross’s 9-11 Recovery Program in New York. Although his involvement was brief, it underscored his commitment to making an impact during a critical time of recovery and rebuilding for the community.